• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Novel 2,4-Diarylaminopyrimidine Derivatives Containing Pyridine Moiety: Design, Synthesis, Crystal Structure and Biological Evaluation①

    2022-03-08 02:30:44LIUJuWUShungWANGHunDUSiYunLIZhenSHENJiWeiCHENYeDINGShi
    結(jié)構(gòu)化學 2022年1期

    LIU Ju WU Shung WANG Hun DU Si-Yun LI Zhen SHEN Ji-Wei CHEN Ye② DING Shi②

    a (College of Pharmacy of Liaoning University, Shenyang 110036, China)

    b (API Engineering Technology Research Center of Liaoning Province, Shenyang 110036, China)

    c (Small Molecular Targeted Drug R&D Engineering Research Center of Liaoning Province, Shenyang 110036, China)

    ABSTRACT A series of 2,4-diarylaminopyrimidine derivatives containing pyridine structure were designed and synthesized. The crystal structures of compounds 5d and 5e were obtained from X-ray diffraction. The crystal structure of 5d (C25H20ClFN6O2) belongs to the monoclinic system, space group P21/c with a = 11.0500(10), b =18.3045(17), c = 13.5646(9) ? and β = 122.806(5)°. 5e (C25H19ClF2N6O2) is of monoclinic system, space group P21/c with a = 10.9998(18), b = 18.517(3), c = 13.6355(16) ? and β = 123.315(9)°. The bioassay results showed all of the target compounds exhibited potential antiproliferative activities against MKN-45, HT-29, A549, K562 and GIST882 cell lines. Among them, compounds 5a, 5c and 5e exhibited remarkable inhibitory activities against GIST882, K562 and A549 cell lines with IC50 values of 0.68, 0.38 and 0.60 μM, respectively, which were comparable to that of the positive control foretinib.

    Keywords: pyrimidine, pyridine, synthesis, X-ray diffraction, antitumor activity;

    1 INTRODUCTION

    Cancer is one of the most health problems in the world.Although many classes of drugs were used for the treatment,the needs for safe and effective anticancer compounds are still significant target[1,2]. Pyridine and pyrimidine-based compounds have been reported to show remarkable antitumor activities by means of inhibiting multiple enzymes, and some of them are already being marketed or are under clinical/preclinical studies, such as imatinib, sorafenib, crizotinib,abiraterone, BMS-794833, altiratinib, and BMS-777607[3-6].Among above compounds, BMS-794833, altiratinib, and BMS-777607 are representative 4-phenoxypyridine based type II c-Met kinase inhibitors[7,8]. Blocking c-Met kinase activity by small-molecule inhibitors has been identified as a promising approach for the treatment of cancers[9].

    As described in Fig. 1, structurally, most of 4-phenoxypyridine type II c-Met inhibitors may be disconnected into three moieties: a 4-phenoxypyridine core (moiety A), a phenyl or substituted phenyl group (moiety B) and a linker bridge(moiety C). Moiety A and moiety B are crucial for kinase activity[10-12]. With the goal of finding more 4-phenoxypyridine-based antitumor agents,N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide was used as the moiety A.Pyrimidine-2,4-diamine was introduced into the moiety Cviacyclization strategy. Furthermore, various substituents were introduced at the phenyl ring (moiety B) to investigate their effects on activities (Fig. 1). Accordingly, a series of 4-phenoxypyridine derivatives were designed, synthesized and evaluated for theirin vitroantiproliferative activities against MKN-45, HT-29, A549, K562 and GIST882 cancer cell lines.

    2 EXPERIMENTAL

    2. 1 Materials and methods

    Unless otherwise specified, all materials were obtained from commercial suppliers and were used without further purification.1H NMR spectra were recorded on a Bruker Biospin 600 MHz instrument using TMS as the internal standard. All chemical shifts were reported in ppm. IR spectra were recorded as KBr pellets on a Perkin-Elmer Spectrum one FT-IR spectrometer. MS spectra were obtained on an Agilent 6460 QQQ mass spectrometer (Agilent, USA) analysis system.Crystal data were obtained on a Bruker P4 X-diffractometer.

    2. 2 Synthesis of N-(4-chloropyridin2-yl)-cyclopropylformamide (1)

    Cyclopropanecarbonyl chloride (9.30 g, 89.00 mmol) was dissolved in dried CH2Cl2(30 mL) and dropwise added to a mixture of 4-chloropyridin-2-amine (8.80 g, 68.45 mmol),Et3N (20.78 g, 205.35 mmol) and CH2Cl2(80 mL) in an ice bath, which was then removed to raise the temperature to room temperature and stirred for 12 h. The resulting mixture was sequentially washed with 20% K2CO3(50 mL × 3) and brine (50 mL × 3), and the organic phase was separated, dried over anhydrous Na2SO4, filtered, and the filtrate was evaporated under reduced pressure. The crude product obtained was purified by silica gel chromatography to give 9.78 g (yield: 73%) of 1 as a white solid. IR (KBr) cm-1:3242(-NH-), 1707(C=O), 1670, 1588(C=N), 1574(Ar),1537(Ar), 1404, 1257, 1213, 1190, 1150, 960, 873, 824, 710;1H NMR (600 MHz, CDCl3)δ8.79 (s, 1H), 8.31 (s, 1H), 8.16(d,J= 5.4 Hz, 1H), 7.03 (dd,J= 5.4, 1.6 Hz, 1H), 1.60~1.49(m, 1H), 1.17~1.09 (m, 2H), 0.97~0.87 (m, 2H); MS (ESI)m/z (%): 197.1 [M+H]+.

    2. 3 Synthesis of N-(4-(2-fluoro-4-nitrophenoxy)pyridin-2-yl)cyclopropylformamide (2)

    A stirring mixture of compound 8 (8.00 g, 40.68 mmol) and 2-fluoro-4-nitrophenol (15.98 g, 101.71 mmol) in chlorobenzene (100 mL) was refluxed for about 40 h. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure to yield a pale solid. The solid was dissolved in CH2Cl2(150 mL), washed with saturated K2CO3aqueous solution (80 mL × 4) and then brine (60 mL × 4),dried over anhydrous Na2SO4, and finally concentrated under reduced pressure to afford a brown solid, which was purified by silica gel chromatography to give 7.13 g (yield: 55%) of 2 as a light yellow solid. IR (KBr) cm-1: 3418(-NH-),1687(C=O), 1617(C=N), 1529(Ar), 1493(Ar), 1354, 1300,1272, 1180, 1070, 875, 798;1H NMR (600 MHz, DMSO-d6)δ11.00 (s, 1H), 8.43 (dd,J= 10.3, 2.2 Hz, 1H), 8.30 (d,J=5.7 Hz, 1H), 8.19 (dd,J= 9.0, 1.9 Hz, 1H), 7.76 (d,J= 2.2 Hz,1H), 7.61 (t,J= 8.5 Hz, 1H), 6.86 (dd,J= 5.6, 2.2 Hz, 1H),2.04~1.95 (m, 1H), 0.78 (t,J= 6.3 Hz, 4H); MS (ESI) m/z(%): 318.1 [M+H]+.

    2. 4 Synthesis of N-(4-(4-amino-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (3)

    A mixture of compound 2 (6.00 g, 18.91 mmol), iron powder (5.28 g, 94.56 mmol), acetic acid (11.36 g, 189.10 mmol), water (20 mL) and ethyl acetate (100 mL) was heated to reflux for 2 h. After completion of the reaction as indicated by TLC, the mixture was filtered immediately. The organic layer of the filtrate was separated, washed with water, dried over anhydrous Na2SO4and filtered, and the filtrate was evaporated under reduced pressure when white solid appeared,which was filtered to obtain 3.51 g (yield: 65%) of 3 as a white solid. IR (KBr) cm-1: 3411(-NH-), 2026, 1737(C=O),1618(C=N), 1510(Ar), 1427, 1207, 1163, 993, 956, 866, 822,610;1H NMR (600 MHz, DMSO-d6)δ10.79 (s, 1H), 8.15 (d,J= 5.7 Hz, 1H), 7.59 (s, 1H), 6.95 (t,J= 9.0 Hz, 1H),6.67~6.61 (m, 1H), 6.49 (dd,J= 13.1, 2.2 Hz, 1H), 6.40 (d,J= 8.7 Hz, 1H), 5.44 (s, 2H), 2.03~1.88 (m, 1H), 0.76 (br, 4H);MS (ESI) m/z (%): 288.1 [M+H]+, 310.1 [M+Na]+.

    2. 5 Synthesis of N-(4-(4-((2-chloropyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropane formamide (4)

    A mixture of compound 3 (3.00 g, 10.44 mmol), 2,4-dichloropyrimidine (1.87 g, 12.53 mmol), and diisopropylethylamine (1.35 g, 10.44 mmol) in isopropanol (50 mL) was heated at reflux for 25 h. Upon cooling to room temperature,the mixture evaporated under reduced pressure. The residue was dissolved in dichloromethane (80 mL), and washed with water (50 mL × 3). The organic layer was dried over anhydrous Na2SO4and concentrated under reduced pressure to afford crude product, which was purified by silica gel chromatography to give 3.17 g (yield: 76%) of 4 as a white solid.1H NMR (600 MHz, DMSO-d6)δ10.90 (s, 1H), 10.34(s, 1H), 8.25~8.22 (m, 2H), 7.88~7.60 (m, 2H), 7.50~7.30 (m,2H), 6.85~6.71 (m, 2H), 2.03~1.92 (m, 1H), 0.84~0.72 (m,4H); MS (ESI) m/z (%): 400.1 [M+H]+, 422.0 [M+Na]+.

    2. 6 General procedure for preparing the target compounds (5a~5f)

    A mixture of compound 4 (0.20 g, 0.50 mmol), aromatic amine (1.3 equivalents) andp-toluenesulfonic acid (1.0 equivalent) in isopropanol (8.0 mL) was refluxed for about 18 h. After cooling to room temperature, the resultant precipitate was filtered and dried under vacuum to afford the target compounds 5a~5f as white solid.

    N-(4-(2-fluoro-4-((2-(phenylamino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5a)

    Yield: 67%;1H NMR (600 MHz, DMSO-d6)δ10.58 (d,J= 13.1 Hz, 1H), 9.37 (d,J= 11.5 Hz, 1H), 9.05~8.80 (m, 1H),8.20~8.06 (m, 2H), 8.02 (d,J= 5.7 Hz, 1H), 7.81~7.62 (m,3H), 7.37 (d,J= 8.4 Hz, 1H), 7.30~7.19 (m, 2H), 7.10 (t,J=8.8 Hz, 1H), 6.91 (t,J= 7.2 Hz, 1H), 6.65~6.50 (m, 1H), 6.22(d,J= 5.7 Hz, 1H), 2.04~1.89 (m, 1H), 0.91~0.83 (m, 2H),0.79~0.72 (m, 2H); MS (ESI) m/z(%): 457.2 [M+H]+, 479.1[M+Na]+.

    N-(4-(2-fluoro-4-((2-((4-fluorophenyl)amino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5b)

    Yield: 59%;1H NMR (600 MHz, DMSO-d6)δ10.74~10.55(m, 1H), 9.53~9.32 (m, 1H), 9.16~8.87 (m, 1H), 8.20~7.92 (m,3H), 7.70 (d,J= 13.4 Hz, 3H), 7.41~7.28 (m, 1H), 7.19~7.04(m, 1H), 7.04~6.88 (m, 2H), 6.64~6.50 (m, 1H), 6.31~6.12 (m,1H), 5.86~5.82 (m, 1H), 2.03~1.88 (m, 1H), 0.96~0.58 (m,4H); IR (KBr, cm-1): 3258(-NH-), 2355, 1678(C=O), 1591,1508(Ar), 1422(Ar), 1312, 1207, 982, 820; MS (ESI) m/z (%):475.2 [M+H]+, 497.1 [M+Na]+.

    N-(4-(4-((2-((4-chlorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (5c)

    Yield: 55%;1H NMR (600 MHz, DMSO-d6)δ10.67~10.45(m, 1H), 9.50~9.31 (m, 1H), 9.18~8.92 (m, 1H), 8.26~7.96 (m,3H), 7.79~7.67 (m, 3H), 7.35 (d,J= 7.3 Hz, 1H), 7.26~7.00(m, 3H), 6.59 (dd,J= 5.7, 2.3 Hz, 1H), 6.24 (d,J= 5.7 Hz,1H), 2.07~1.86 (m, 1H), 0.90~0.83 (m, 2H), 0.79~0.73 (m,2H); IR (KBr, cm-1): 3281(-NH-), 2353, 1672(C=O), 1585,1416(Ar), 1308, 1204, 1094, 978, 804, 687; MS (ESI) m/z(%): 491.1 [M+H]+, 513.1 [M+Na]+.

    N-(4-(4-((2-((3-chlorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-2-yl)cyclopropanecarboxamide (5d)

    Yield: 57%;1H NMR (600 MHz, DMSO-d6)δ10.51 (br,1H), 9.36 (br, 1H), 9.17~9.04 (m, 1H), 8.13 (d,J= 5.7 Hz,1H), 8.04 (d,J= 5.7 Hz, 1H), 7.95 (s, 1H), 7.92~7.83 (m, 1H),7.74 (d,J= 1.9 Hz, 1H), 7.57 (d,J= 8.2 Hz, 1H), 7.41 (d,J=8.8 Hz, 1H), 7.18 (t,J= 8.1 Hz, 1H), 7.12 (t,J= 8.8 Hz, 1H),6.87 (d,J= 7.9 Hz, 1H), 6.60~6.55 (m, 1H), 6.31~6.22 (m,1H), 2.03~1.84 (m, 1H), 0.91~0.86 (m, 2H), 0.79~0.74 (m,2H); IR (KBr, cm-1): 3305(-NH-), 2357, 1679(C=O), 1619,1416, 1314, 1207, 1105, 990, 808; MS (ESI) m/z (%): 491.1[M+H]+, 513.1 [M+Na]+.

    N-(4-(4-((2-((3-chloro-4-fluorophenyl)amino)pyrimidin-4-yl)amino)-2-fluorophenoxy)pyridin-

    2-yl)cyclopropanecarboxamide (5e)

    Yield: 45%;1H NMR (600 MHz, DMSO-d6)δ10.76~10.50(m, 1H), 9.48 (d,J= 13.0 Hz, 1H), 9.25 (d,J= 13.9 Hz, 1H),8.17~8.10 (m, 1H), 8.06~7.97 (m, 3H), 7.71 (d,J= 3.4 Hz,1H), 7.58 (br, 1H), 7.45~7.33 (m, 1H), 7.20~7.03 (m, 2H),6.64~6.54 (m, 1H), 6.26 (t,J= 6.8 Hz, 1H), 1.97 (d,J= 4.1 Hz, 1H), 0.92~0.71 (m, 4H); IR (KBr, cm-1): 3269(-NH-),2349, 1678(C=O), 1591, 1413(Ar), 1310, 1259, 1207, 1101,990, 808; MS (ESI) m/z (%): 509.1 [M+H]+, 531.1 [M+Na]+.

    N-(4-(2-fluoro-4-((2-(p-tolylamino)pyrimidin-4-yl)amino)phenoxy)pyridin-2-yl)cyclopropanecarboxamide (5f)

    Yield: 62%;1H NMR (600 MHz, DMSO-d6)δ10.63 (s,1H), 9.38 (s, 1H), 8.85 (s, 1H), 8.16~8.08 (m, 2H), 8.00 (d,J= 0.6 Hz, 1H), 7.72 (s, 1H), 7.57 (d,J= 8.3 Hz, 2H), 7.37 (d,J= 8.7 Hz, 1H), 7.10 (t,J= 8.9 Hz, 1H), 7.07~7.01 (m, 2H),6.59 (dd,J= 5.7, 2.3 Hz, 1H), 6.19 (d,J= 5.7 Hz, 1H), 2.27(s, 3H), 2.05~1.90 (m, 1H), 0.89~0.82 (m, 2H), 0.79~0.72 (m,2H); IR (KBr, cm-1): 3196(-NH-), 3017, 2363, 1680(C=O),1586, 1524(Ar), 1420, 1308, 1206, 1101, 986, 804, 700; MS(ESI) m/z (%): 471.2 [M+H]+, 493.2 [M+Na]+.

    2. 7 X-ray data collection and structure refinement

    The white powder of compounds 5d and 5e was dissolved in ethanol/ethyl acetate/tetrahydrofuran = 5:2:3 (V/V/V) and 5:3:1 (V/V/V) mixed solvents, respectively. After slowly evaporating the solvents for several days, some single crystals suitable for X-ray analysis were obtained. The X-ray crystallography data for two crystals were collected on a Bruker APEX-II CCD automatic diffractometer with graphite-monochromatized MoKaradiation (λ= 0.71073 ?)using theφandω-scan mode at 296(2) K. The structure was solved by direct methods and refined with the SHELX crystallographic software package[13]and expanded by Fourier technique. The non-hydrogen atoms were refined anisotropically. The hydrogen atoms bound to carbon were determined with theoretical calculations and those attached to nitrogen and oxygen were determined with successive difference Fourier syntheses. Empirical absorption correction was applied. The structure was solved by direct methods using SADABS[14]. The hydrogen atoms were placed at the calculated positions and refined as riding atoms with isotropic displacement parameters[15]. Crystallographic data and experimental details of structural analyses for 5d and 5e are summarized in Table 1. The hydrogen bonds of the title compound are listed in Table 2, and geometric parameters for it can be found in Table 3.

    Table 1. Crystal Data of Compounds 5d and 5e

    Table 2. Hydrogen Bond Lengths (?) and Bond Angles ( ) of 5d and 5e

    Table 3. Geometric Parameters of 5d and 5e

    C(11)–C(12) 1.388(5) 1.396(4) N(5)–C(19)–N(6) 114.7(3) 114.5(2)C(11)–N(4) 1.401(4) 1.405(3) C(22)–C(23)–C(24) 117.5(3) 115.9(3)C(14)–O(1) 1.382(4) 1.398(3) C(24)–C(23)–C(25) 58.5(3) 58.6(2)C(17)–C(18) 1.377(4) 1.377(4) C(7)–N(1)–C(1) 127.6(3) 127.6(2)C(17)–O(1) 1.379(4) 1.379(3) C(7)–N(2)–C(10) 116.0(3) 115.9(2)C(19)–N(5) 1.333(4) 1.338(3) C(7)–N(3)–C(8) 113.8(3) 113.9(2)C(19)–N(6) 1.399(4) 1.398(3) C(22)–N(6)–C(19) 126.2(3) 126.2(2)C(22)–O(2) 1.226(4) 1.230(3) C(17)–O(1)–C(14) 117.7(2) 116.8(2)C(22)–N(6) 1.362(4) 1.358(3) N(1)–C(1)–C(2)–C(3) –177.3(3) 175.3(2)C(22)–C(23) 1.471(5) 1.464(4) O(1)–C(14)–C(15)–C(16) 178.5(3) 178.3(2 C(23)–C(24) 1.507(5) 1.509(4) N(2)–C(7)–N(1)–C(1) –7.6(5) 6.1(4)C(24)–C(25) 1.477(6) 1.469(4) N(6)–C(22)–C(23)–C(25) –133.3(3) –163.5(2)

    2. 8 In vitro anticancer activity test of the target compounds

    The antiproliferative activities of compounds 5a~5f were evaluated against human gastric cancer cell lines MKN-45,human colon cancer cell lines HT-29, human lung adenocarcinoma cell lines A549, human chronic myeloid leukemia cell lines K562 and human gastrointestinal stromal tumor cell lines GIST882 using the standard MTT assayin vitro, with Foretinib as the positive control. The cancer cell lines were cultured in minimum essential medium (MEM)supplement with 10% fetal bovine serum (FBS). Approximate 4 × 103cells, suspended in MEM medium, were plated onto each well of a 96-well plate and incubated in 5% CO2at 37 C for 24 h. The tested compounds at the indicated final concentrations were added to the culture medium and the cell cultures were continued for 72 h. Fresh MTT was added to each well at a terminal concentration of 5 μg/mL, and incubated with cells at 37 C for 4 h. The formazan crystals were dissolved in 100 mL DMSO each well, and the absorbency at 492 nm (for absorbance of MTT formazan) and 630 nm (for the reference wavelength) was measured with an ELISA reader. All compounds were tested three times in each cell line. The results expressed as IC50(inhibitory concentration 50%) were the averages of three determinations and calculated by using the Bacus Laboratories Incorporated Slide Scanner (Bliss) software.

    3 RESULTS AND DISCUSSION

    3. 1 Synthesis

    The syntheses of target compounds 5a~5f were outlined in Scheme 1. Commercially available 4-chloropyridin-2-amine was condensed with cyclopropanecarbonyl chloride in the presence of Et3N to provide 1, which underwent a nucleophilic substitution with 2-fluoro-4-nitrophenol to give the desired intermediate 2. Reduction of the nitro group of 2 with iron powder and acetic acid in ethyl acetate/water (10:1 v/v)provided aniline compound 3. 3 reacted with 2,4-dichloropyrimidine in refluxingi-PrOH to provide key intermediate 4 under the catalysis of DIPEA. 4 reacted with different substituted anilines in the presence ofp-toluenesulfonic acid in refluxingi-PrOH to yield the target compounds 5a-5f, and the their structures were confirmed by1H NMR, IR and ESI-MS.

    Scheme 1. Synthetic route and structure of target compounds

    3. 2 Crystal structures

    The structures of compounds 5d and 5e were further confirmed by single-crystal X-ray diffraction analysis. The molecular structures of compounds 5d and 5e with atom-numbering are shown in Fig. 2. Both crystal structures of 5d and 5e crystallize in monoclinic space groupP21/c.Their crystal structures show that the two molecules have a 2,4-diarylaminopyrimidine skeleton, in which all bond lengths and bond angles fall in normal ranges. Both of the crystal structures consist of five rings: a three-membered cyclopropane (A), a pyrimidine ring (B), a pyridine ring (C) and two benzene rings (D, E). For compound 5d, the molecule is not coplanar because the dihedral angles between rings A, B and C are 75.44° (A/C), 78.30° (A/B), 61.80° (A/D) and 33.91°(A/E), indicating rings B and C are almost perpendicular to ring A. For compound 5e, the molecule is also not coplanar because the dihedral angles between rings A, B, C, D and E are 75.12° (A/C), 77.42° (A/B), 61.87° (A/D) and 47.67°(A/D), so similar perpendicular conformation is also found.For compounds 5d and 5e, the bond lengths of C(22)–O(2)are 1.226(4) and 1.230(3) ? belonging to the typical C=O double bond[16]. Meanwhile, hydrogen bonding interactions play a significant role in the crystal packing of 5d and 5e(Table 2). A mass of intermolecular hydrogen bonds N(4)–H(4A) O(2), N(3)–H(6A) N(6) and N(6)–H(6) N(3)found in the two compounds play a major role in stabilizing the molecule. And the molecular structures of compounds 5d and 5e are shown in Fig. 3, depicting the molecular packing and hydrogen bonds in a unit cell. Within the molecule, the bond lengths and bond angles present no unusual features.

    Fig. 1. The representative 4-phenoxypyridine type II c-Met kinase inhibitors and design strategy of the target compounds

    Fig. 2. Molecular structure of compound 5d and 5e in a single crystal at 296 K

    3. 3 Biological activity analysis

    Fig. 3. Crystal packing diagrams of compounds 5d and 5e

    The IC50values of 5a~5f and Foretinib against MKN-45,HT-29, A549, K562 and GIST882 cancer cells are presented in Table 4, in which all the tested compounds show excellent antiproliferative activities against different cancer cells with IC50values ranging from 0.38 to 6.29 μM, indicating that newly synthesized 4-phenoxypyridine derivatives maintained antitumor activities. Notably, compounds 5a (R1= H), 5c (R1= 4-Cl) and 5e (R1= 3-Cl-4-F) exhibited remarkable antiproliferative activities against GIST882, K562 and A549 cell lines with IC50values of 0.68 μM (foretinib: 0.75 μM), 0.38 μM(foretinib: 0.39 μM) and 0.60 μM (foretinib: 0.94 μM),respectively, which were all better than the positive control foretinib.

    Table 4. Antiproliferative Activities of Target Compounds against Some Cancer Cells in vitro

    3. 4 Physicochemical and ADME parameters

    Furthermore, some physicochemical and ADME properties of the synthesized compounds and positive controls were predicted using the SwissADME (a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules) for their adaptability with Lipinski's rule of five[17-19]. Compounds obeying at least three of the four criteria are considered to adhere to Lipinski Rule.

    As demonstrated in Table 5, the most active compounds show variable permeability based on gastrointestinal absorption (GI), according to the BOILED-Egg predictive model (Brain Or IntestinaL EstimateD permeation method).All predicted compounds showed high gastrointestinal absorption. With respect to oral bioavailability, it is expected 0.55 of probability of oral bioavailability score >10% in the rat for all compounds, the same as the control drug foretinib(0.55). Compound 5a~5f exhibited potentin vitroantitumor activity, low toxicity and reasonable physicochemical properties, because suitable flexible and size in the bioavailability radar map (Fig. 4). All these data suggests that compound 5a~5f could be considered as a candidate for further research.

    Fig. 4. The bioavailability radar enables a first glance at the drug-likeness of target compounds and Foretinib. The pink area represents the optimal range for each properties (lipophilicity: XLOGP3 between –0.7 and +5.0, size: MW between 150 and 500 g/mol, polarity:TPSA between 20 and 130 ?2, solubility: logS not higher than 6, saturation: fraction of carbons in the sp3 hybridization not less than 0.25, and flexibility: no more than 9 rotatable bonds.

    Table 5. Physicochemical Properties and ADME Properties of Target Compounds

    Electronic supplementary information

    Supplementary data associated with this article have been deposited in the ESI.

    插逼视频在线观看| 超碰av人人做人人爽久久| 看免费成人av毛片| 精品久久久久久久人妻蜜臀av| 欧美成人a在线观看| 一本久久中文字幕| 国模一区二区三区四区视频| 在线观看美女被高潮喷水网站| 18禁黄网站禁片免费观看直播| 婷婷精品国产亚洲av在线| 婷婷精品国产亚洲av在线| 国产高潮美女av| 国产毛片a区久久久久| 特级一级黄色大片| 亚洲av中文字字幕乱码综合| 亚洲欧美成人精品一区二区| 97超碰精品成人国产| 国产亚洲精品综合一区在线观看| 51国产日韩欧美| 亚洲精品影视一区二区三区av| 欧美性猛交黑人性爽| 中文字幕熟女人妻在线| 久久综合国产亚洲精品| 丝袜美腿在线中文| 美女内射精品一级片tv| 国产亚洲av嫩草精品影院| 国产精品嫩草影院av在线观看| 天天躁日日操中文字幕| 美女cb高潮喷水在线观看| 一进一出抽搐动态| 久久6这里有精品| 午夜激情欧美在线| 波多野结衣巨乳人妻| 国产极品精品免费视频能看的| 亚洲欧美日韩无卡精品| 我要搜黄色片| 亚洲一区高清亚洲精品| 免费av观看视频| 亚洲第一区二区三区不卡| 精品久久久久久久久亚洲| 欧美性感艳星| 又爽又黄无遮挡网站| 波多野结衣巨乳人妻| 午夜福利在线观看免费完整高清在 | 又黄又爽又刺激的免费视频.| 91狼人影院| 国内少妇人妻偷人精品xxx网站| 精品国产三级普通话版| 一级毛片久久久久久久久女| 久久草成人影院| 午夜免费男女啪啪视频观看 | 能在线免费观看的黄片| 日本一本二区三区精品| 国产精品一区二区性色av| 亚洲av美国av| 性色avwww在线观看| 亚洲欧美精品综合久久99| 亚洲欧美成人精品一区二区| 亚洲成人精品中文字幕电影| а√天堂www在线а√下载| 欧美色欧美亚洲另类二区| 青春草视频在线免费观看| 高清午夜精品一区二区三区 | 美女xxoo啪啪120秒动态图| 国产精品一区www在线观看| 亚洲精品乱码久久久v下载方式| 国产亚洲精品综合一区在线观看| 国产精品久久久久久亚洲av鲁大| 亚洲精品色激情综合| 日日摸夜夜添夜夜爱| 久久99热6这里只有精品| a级一级毛片免费在线观看| 国产女主播在线喷水免费视频网站 | 性插视频无遮挡在线免费观看| 亚洲人与动物交配视频| 99久久精品国产国产毛片| 黄色日韩在线| 六月丁香七月| 99久久无色码亚洲精品果冻| 国产日本99.免费观看| 国产精品嫩草影院av在线观看| 欧美一区二区亚洲| 国产一区二区在线av高清观看| 久久精品国产自在天天线| 精品一区二区免费观看| 亚洲精品日韩在线中文字幕 | 亚洲av五月六月丁香网| 99久久久亚洲精品蜜臀av| 国产午夜精品久久久久久一区二区三区 | 亚洲真实伦在线观看| 久久人人精品亚洲av| 亚洲精品色激情综合| 欧美bdsm另类| 丰满乱子伦码专区| 日韩av在线大香蕉| 51国产日韩欧美| 高清毛片免费看| 美女被艹到高潮喷水动态| 国产精品一区二区三区四区免费观看 | 亚洲精品日韩av片在线观看| eeuss影院久久| 久久这里只有精品中国| 一本一本综合久久| 精品久久久久久久久久免费视频| 国产精品一区二区性色av| 国产一区亚洲一区在线观看| 老司机影院成人| 久久久久久久亚洲中文字幕| 国产色爽女视频免费观看| 插逼视频在线观看| 国产一级毛片七仙女欲春2| 日韩精品青青久久久久久| 亚洲成人精品中文字幕电影| 国产一区亚洲一区在线观看| 一区二区三区四区激情视频 | 国产亚洲91精品色在线| 亚洲最大成人av| 99久国产av精品国产电影| 亚洲成a人片在线一区二区| a级一级毛片免费在线观看| 亚洲精品日韩在线中文字幕 | 亚洲av免费高清在线观看| 久久久a久久爽久久v久久| 亚洲国产高清在线一区二区三| 国产不卡一卡二| 搡老妇女老女人老熟妇| 久久久久精品国产欧美久久久| 久久精品国产亚洲av涩爱 | 综合色av麻豆| 亚洲久久久久久中文字幕| 伊人久久精品亚洲午夜| 久久人人精品亚洲av| 免费观看人在逋| a级毛色黄片| 亚洲最大成人手机在线| 淫妇啪啪啪对白视频| 国产一级毛片七仙女欲春2| 久久久久久久久大av| 97热精品久久久久久| 精品久久久久久久久久久久久| 91在线观看av| ponron亚洲| 九色成人免费人妻av| 成人av在线播放网站| 赤兔流量卡办理| 亚洲真实伦在线观看| 99九九线精品视频在线观看视频| 秋霞在线观看毛片| 亚洲av五月六月丁香网| 国产亚洲91精品色在线| 美女高潮的动态| 亚洲国产精品合色在线| 美女黄网站色视频| 午夜激情福利司机影院| 国语自产精品视频在线第100页| 精品人妻视频免费看| 夜夜爽天天搞| 大又大粗又爽又黄少妇毛片口| 精品熟女少妇av免费看| av在线天堂中文字幕| 国产精品伦人一区二区| 国产高清不卡午夜福利| 国产一区二区在线av高清观看| 毛片女人毛片| 国产精品不卡视频一区二区| 久久亚洲精品不卡| 老司机影院成人| 日韩欧美在线乱码| 久久精品国产自在天天线| 男女视频在线观看网站免费| 在线播放国产精品三级| 日韩精品青青久久久久久| 国产成人福利小说| 成人亚洲精品av一区二区| 国产精品国产高清国产av| 国产成人91sexporn| 国产精品嫩草影院av在线观看| 一本精品99久久精品77| 日韩精品青青久久久久久| 久久综合国产亚洲精品| 国产 一区 欧美 日韩| 国产精品综合久久久久久久免费| 国产成人福利小说| 又爽又黄无遮挡网站| 黄色一级大片看看| 色吧在线观看| 又爽又黄无遮挡网站| 国产高清不卡午夜福利| 国产高清视频在线观看网站| 国产单亲对白刺激| 免费av不卡在线播放| 在线免费观看的www视频| 熟女人妻精品中文字幕| 国产高清不卡午夜福利| 国产一区二区在线av高清观看| 插阴视频在线观看视频| 精品久久久噜噜| 最好的美女福利视频网| 欧美成人一区二区免费高清观看| av在线老鸭窝| 国产真实伦视频高清在线观看| 麻豆国产97在线/欧美| 在线看三级毛片| 欧美激情国产日韩精品一区| 国产精品免费一区二区三区在线| 国产精品久久视频播放| 搡老熟女国产l中国老女人| 搡女人真爽免费视频火全软件 | 99久久精品一区二区三区| 2021天堂中文幕一二区在线观| 淫秽高清视频在线观看| 国产aⅴ精品一区二区三区波| 精品福利观看| 波多野结衣高清作品| 51国产日韩欧美| 黄色配什么色好看| 天堂动漫精品| 干丝袜人妻中文字幕| 日韩精品中文字幕看吧| 97在线视频观看| 人妻久久中文字幕网| 免费av不卡在线播放| 国产高清视频在线观看网站| 欧美3d第一页| 中文亚洲av片在线观看爽| 日韩强制内射视频| 99热这里只有是精品50| 国产一区二区三区av在线 | 韩国av在线不卡| 久久鲁丝午夜福利片| 国产精品免费一区二区三区在线| 亚洲欧美中文字幕日韩二区| 婷婷亚洲欧美| 九九热线精品视视频播放| 亚洲精品456在线播放app| 成人特级黄色片久久久久久久| 国产乱人视频| 亚洲欧美日韩卡通动漫| 直男gayav资源| 欧美三级亚洲精品| 亚洲av熟女| 日本三级黄在线观看| 日韩精品中文字幕看吧| 国产精品一区二区性色av| 搡女人真爽免费视频火全软件 | 亚洲高清免费不卡视频| 久久精品国产亚洲av天美| 波野结衣二区三区在线| 搡女人真爽免费视频火全软件 | 亚洲一区高清亚洲精品| 日本熟妇午夜| 欧美日韩精品成人综合77777| 欧美性感艳星| 精品午夜福利视频在线观看一区| 不卡视频在线观看欧美| 国产黄a三级三级三级人| 成人鲁丝片一二三区免费| 99视频精品全部免费 在线| 久久精品综合一区二区三区| 国产aⅴ精品一区二区三区波| 国产女主播在线喷水免费视频网站 | 国产69精品久久久久777片| 国语自产精品视频在线第100页| 丰满人妻一区二区三区视频av| 能在线免费观看的黄片| 日本黄色视频三级网站网址| 日韩欧美免费精品| 亚洲三级黄色毛片| 久久这里只有精品中国| 日本黄色片子视频| 国产高清视频在线播放一区| 18禁裸乳无遮挡免费网站照片| 联通29元200g的流量卡| 色综合亚洲欧美另类图片| 国产欧美日韩精品一区二区| 国产精品免费一区二区三区在线| 久久午夜亚洲精品久久| 久久鲁丝午夜福利片| 男女边吃奶边做爰视频| 精品久久久久久久久久免费视频| 97人妻精品一区二区三区麻豆| 成人无遮挡网站| av在线亚洲专区| 亚洲av免费在线观看| 久久精品国产99精品国产亚洲性色| 一级黄色大片毛片| 偷拍熟女少妇极品色| 男女那种视频在线观看| 国产一区二区在线观看日韩| 久久久色成人| 国产视频一区二区在线看| av在线天堂中文字幕| 丝袜喷水一区| 亚洲欧美成人综合另类久久久 | 欧美成人a在线观看| 91在线观看av| 色哟哟·www| 日本三级黄在线观看| 欧美日本亚洲视频在线播放| 热99re8久久精品国产| 精品福利观看| 91在线精品国自产拍蜜月| a级一级毛片免费在线观看| 久久精品国产清高在天天线| 日本黄色片子视频| 午夜影院日韩av| 亚洲国产精品成人久久小说 | 一级a爱片免费观看的视频| 禁无遮挡网站| 黄色日韩在线| 少妇裸体淫交视频免费看高清| 三级毛片av免费| 色5月婷婷丁香| 级片在线观看| 伦精品一区二区三区| 18禁黄网站禁片免费观看直播| 日本a在线网址| 国产精品永久免费网站| 欧美日韩一区二区视频在线观看视频在线 | 亚洲最大成人av| 极品教师在线视频| 亚洲成人av在线免费| a级毛片a级免费在线| 免费黄网站久久成人精品| 欧美激情久久久久久爽电影| 亚洲18禁久久av| 亚洲欧美精品综合久久99| 精品一区二区三区视频在线观看免费| 久久久久久久久久黄片| 性欧美人与动物交配| 国产成人一区二区在线| 欧美日韩在线观看h| 欧美xxxx黑人xx丫x性爽| 亚洲三级黄色毛片| 国产女主播在线喷水免费视频网站 | 日本与韩国留学比较| 中国国产av一级| 亚洲成人久久爱视频| 亚洲丝袜综合中文字幕| 身体一侧抽搐| 色综合站精品国产| 久久久国产成人精品二区| 变态另类成人亚洲欧美熟女| 女生性感内裤真人,穿戴方法视频| 在线免费十八禁| 欧美日本视频| 一级a爱片免费观看的视频| 久久午夜福利片| 黄色欧美视频在线观看| 日日啪夜夜撸| 夜夜爽天天搞| av专区在线播放| 精品国产三级普通话版| 最近2019中文字幕mv第一页| 在线观看免费视频日本深夜| 男人的好看免费观看在线视频| 亚洲最大成人中文| 日本爱情动作片www.在线观看 | 搞女人的毛片| 中文字幕av在线有码专区| 国产一区二区三区av在线 | 欧美在线一区亚洲| av专区在线播放| 精品国产三级普通话版| 久久人人爽人人片av| 两性午夜刺激爽爽歪歪视频在线观看| 在线观看一区二区三区| 97超级碰碰碰精品色视频在线观看| 夜夜看夜夜爽夜夜摸| 久久6这里有精品| 丝袜喷水一区| 菩萨蛮人人尽说江南好唐韦庄 | 看十八女毛片水多多多| 深夜a级毛片| 一本久久中文字幕| 国产在视频线在精品| 国产av在哪里看| 中国美女看黄片| 久久久久久久久久成人| 女生性感内裤真人,穿戴方法视频| 欧美丝袜亚洲另类| 欧美不卡视频在线免费观看| 欧美3d第一页| 成人美女网站在线观看视频| 村上凉子中文字幕在线| 亚洲婷婷狠狠爱综合网| 成人美女网站在线观看视频| 神马国产精品三级电影在线观看| 在线观看美女被高潮喷水网站| 亚洲第一电影网av| 日韩人妻高清精品专区| 天天躁日日操中文字幕| 中国美白少妇内射xxxbb| 久久中文看片网| 色视频www国产| 成人特级黄色片久久久久久久| 97在线视频观看| av黄色大香蕉| 日本与韩国留学比较| 99在线视频只有这里精品首页| 精品少妇黑人巨大在线播放 | 中文字幕精品亚洲无线码一区| 国产高清不卡午夜福利| 国产精品久久视频播放| 亚洲经典国产精华液单| 18禁在线无遮挡免费观看视频 | 性插视频无遮挡在线免费观看| 欧美绝顶高潮抽搐喷水| 男女视频在线观看网站免费| 99久久九九国产精品国产免费| 日本免费a在线| 精品国内亚洲2022精品成人| 成年女人永久免费观看视频| 免费观看精品视频网站| 亚洲熟妇熟女久久| 久久久欧美国产精品| 欧美一区二区亚洲| 亚洲色图av天堂| 一级毛片我不卡| 寂寞人妻少妇视频99o| 亚洲欧美日韩高清专用| 久久精品人妻少妇| 麻豆av噜噜一区二区三区| 久久国产乱子免费精品| 国产乱人偷精品视频| 国产精品一及| 国产精品野战在线观看| 国产亚洲91精品色在线| 欧美国产日韩亚洲一区| 久久国产乱子免费精品| 亚洲成人中文字幕在线播放| 一夜夜www| 看片在线看免费视频| 色吧在线观看| 女人被狂操c到高潮| 天天躁夜夜躁狠狠久久av| 久久天躁狠狠躁夜夜2o2o| 特级一级黄色大片| 国产一区二区激情短视频| 国产高清三级在线| 久久99热这里只有精品18| 日本在线视频免费播放| 亚洲成人中文字幕在线播放| 国产在视频线在精品| 长腿黑丝高跟| 国产精品人妻久久久久久| 亚洲av第一区精品v没综合| 国产精品乱码一区二三区的特点| 色哟哟·www| 搡老熟女国产l中国老女人| 少妇裸体淫交视频免费看高清| 天堂av国产一区二区熟女人妻| 精品久久国产蜜桃| 精品少妇黑人巨大在线播放 | 此物有八面人人有两片| 色av中文字幕| 中文字幕av成人在线电影| 成人鲁丝片一二三区免费| 久久精品夜夜夜夜夜久久蜜豆| 久久久国产成人精品二区| 国产高清激情床上av| 久久草成人影院| 午夜福利18| 欧美性猛交黑人性爽| 久久久色成人| .国产精品久久| 一个人免费在线观看电影| 国产激情偷乱视频一区二区| 最新中文字幕久久久久| 老司机午夜福利在线观看视频| av天堂中文字幕网| 女人十人毛片免费观看3o分钟| 可以在线观看毛片的网站| 日韩三级伦理在线观看| 级片在线观看| 国产高清激情床上av| 91精品国产九色| 少妇人妻一区二区三区视频| 亚洲成a人片在线一区二区| 欧美+亚洲+日韩+国产| 国内精品宾馆在线| 亚洲经典国产精华液单| 日本a在线网址| 欧美+日韩+精品| 综合色av麻豆| 亚洲丝袜综合中文字幕| 亚洲熟妇中文字幕五十中出| 国产视频内射| 在线a可以看的网站| 日日摸夜夜添夜夜爱| 中文字幕久久专区| 午夜福利18| 日本撒尿小便嘘嘘汇集6| 午夜福利高清视频| 精品一区二区三区视频在线| 免费观看在线日韩| 久久九九热精品免费| 亚洲中文字幕日韩| 久久精品夜色国产| 亚洲精品日韩av片在线观看| 久久久久久久亚洲中文字幕| 18禁在线播放成人免费| 国产精品1区2区在线观看.| 国产真实乱freesex| 美女大奶头视频| 国产 一区 欧美 日韩| a级毛片a级免费在线| 成年版毛片免费区| 亚洲国产精品成人久久小说 | eeuss影院久久| 亚洲在线观看片| 国产精品女同一区二区软件| 日本成人三级电影网站| 乱系列少妇在线播放| 亚洲国产精品sss在线观看| 久久久久精品国产欧美久久久| 日本精品一区二区三区蜜桃| 久久久欧美国产精品| 性插视频无遮挡在线免费观看| 亚洲欧美精品自产自拍| 成年免费大片在线观看| 一进一出好大好爽视频| 18+在线观看网站| av视频在线观看入口| 亚洲电影在线观看av| 最近2019中文字幕mv第一页| av国产免费在线观看| 国产色爽女视频免费观看| 99九九线精品视频在线观看视频| 日本熟妇午夜| 一个人观看的视频www高清免费观看| 小说图片视频综合网站| 欧美xxxx性猛交bbbb| 欧美日韩精品成人综合77777| 亚洲第一电影网av| 激情 狠狠 欧美| 精品不卡国产一区二区三区| 中文字幕精品亚洲无线码一区| 日韩欧美精品v在线| 老师上课跳d突然被开到最大视频| 欧美精品国产亚洲| 亚洲欧美日韩东京热| 国产亚洲精品久久久com| 亚洲欧美日韩无卡精品| 亚洲在线观看片| а√天堂www在线а√下载| 我的老师免费观看完整版| 性欧美人与动物交配| 我的女老师完整版在线观看| 欧美日韩国产亚洲二区| 久久九九热精品免费| 日本色播在线视频| 亚洲欧美日韩高清在线视频| 免费观看人在逋| 精品一区二区三区人妻视频| 午夜福利成人在线免费观看| 国国产精品蜜臀av免费| 亚洲经典国产精华液单| 久久久久性生活片| 97超视频在线观看视频| 国产伦一二天堂av在线观看| 精品欧美国产一区二区三| 亚洲国产精品sss在线观看| 日韩大尺度精品在线看网址| 免费人成视频x8x8入口观看| 97碰自拍视频| 中文在线观看免费www的网站| 国产一区二区激情短视频| 国产黄片美女视频| 亚洲人与动物交配视频| 久久精品国产清高在天天线| 欧美激情国产日韩精品一区| 毛片一级片免费看久久久久| 国产爱豆传媒在线观看| 九九爱精品视频在线观看| 久久精品影院6| 久久精品国产亚洲av涩爱 | 亚洲高清免费不卡视频| 日本免费一区二区三区高清不卡| 麻豆精品久久久久久蜜桃| 男人舔女人下体高潮全视频| 亚洲在线观看片| 男女之事视频高清在线观看| 在线观看免费视频日本深夜| 久久人人爽人人片av| 国产一区二区在线观看日韩| 欧美一级a爱片免费观看看| 综合色丁香网| 精品不卡国产一区二区三区| 美女 人体艺术 gogo| 男女做爰动态图高潮gif福利片| 淫妇啪啪啪对白视频| 偷拍熟女少妇极品色| 午夜福利在线观看免费完整高清在 | 可以在线观看的亚洲视频| 日韩欧美一区二区三区在线观看| 看片在线看免费视频| 一边摸一边抽搐一进一小说| 亚洲成人精品中文字幕电影| 国产色爽女视频免费观看| 久久综合国产亚洲精品| 你懂的网址亚洲精品在线观看 | 久久久午夜欧美精品| 成年av动漫网址| 国产一区二区在线av高清观看| 国产亚洲精品综合一区在线观看| 69人妻影院| 日本黄色视频三级网站网址| 97超级碰碰碰精品色视频在线观看| 国产精品av视频在线免费观看| 啦啦啦观看免费观看视频高清| 欧美日韩乱码在线| 午夜福利在线观看免费完整高清在 | 国产男人的电影天堂91| 成人一区二区视频在线观看|